This HTML5 document contains 165 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
n12http://dx.doi.org/10.1093/JAC/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q30830558
rdf:type
wikibase:Item
schema:description
2014年论文 vedecký článok мақолаи илмӣ vědecký článek мақолаи илмӣ 2014 թուականի Յունիսին հրատարակուած գիտական յօդուած научни чланак artykuł naukowy 2014年论文 2014年論文 2014 nî lūn-bûn სამეცნიერო სტატია wetenschappelijk artikel 2014年论文 artikull shkencor artículo científico publicado en 2014 επιστημονικό άρθρο articol științific ২০১৪-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ научна статия tieteellinen artikkeli videnskabelig artikel (udgivet 2014) 2014年の論文 наукова стаття, опублікована в червні 2014 article scientific artigo científico artigo científico (publicado na 2014) scientific article mokslinis straipsnis سائنسی مضمون 2014年論文 2014 թվականի հունիսին հրատարակված գիտական հոդված 2014年論文 2014년 논문 bài báo khoa học vitskapeleg artikkel artigo científico (publicado na 2014) naučni članak 2014年论文 articolo scientifico article científic מאמר מדעי bilimsel makale wissenschaftlicher Artikel 2014年论文 article scientifique (publié 2014) scienca artikolo 2014年論文 научни чланак vetenskaplig artikel vitenskapelig artikkel tudományos cikk 2014年论文 2014年論文 مقالهٔ علمی artikulong pang-agham artículu científicu espublizáu en 2014 บทความทางวิทยาศาสตร์ teaduslik artikkel научная статья مقالة علمية (نشرت في 11-6-2014)
p:P577
wds:Q30830558-A55CB269-3FAC-4526-A61C-7C6B01D53C37
wdt:P577
2014-06-11T00:00:00Z
p:P407
wds:Q30830558-4FECB59E-B5ED-441B-BD04-8BF0D6D41FF3
wdt:P407
wd:Q1860
p:P2860
wds:Q30830558-45CD1975-5097-414D-BD9D-9CBB39A603E4 wds:Q30830558-54813E6D-05B1-4A4B-A51E-41854DC21693 wds:Q30830558-65C27297-33C1-4468-A809-07FB05923234 wds:Q30830558-8273B5A4-EB57-4BE1-8ADC-340CF87CD245 wds:Q30830558-901BFA16-98D4-4B1F-9FBF-7B916B7BA2D4 wds:Q30830558-91D48A0D-6080-4C32-AA20-A939492E8273 wds:Q30830558-A925568D-FFCB-443B-884C-C829EBD9C0B3 wds:Q30830558-ABC694B0-D271-4A98-85C4-557ABAF31ECE wds:Q30830558-C06FF1C6-50C9-420F-A7AB-11A91158EB95 wds:Q30830558-C1ED7B96-E0FA-46B3-96A9-0146E7EC3288 wds:Q30830558-D4234C07-1F30-43C6-8BE0-E98778157532 wds:Q30830558-D46E0257-E60B-49E3-B7D0-591B2E405788 wds:Q30830558-E14DC0BC-C681-49D3-9149-ACFC7F3CEF58 wds:Q30830558-E65CAA0E-5C4F-4237-B0A9-23597C4D0804 wds:Q30830558-E7BE24F0-5BD2-4FEC-B5A7-CE0F0F4FC508 wds:Q30830558-E8FB3791-D9D1-4863-AAB5-575F86233033 wds:Q30830558-04F93864-78E8-4076-AEC6-A20CB9D08822 wds:Q30830558-0D995E63-B259-4808-A595-1A27D70C4AD1 wds:Q30830558-10F15C22-AED4-4771-87E8-7E9BC303323D wds:Q30830558-1DA0B20B-DA31-4E6C-9319-115E2794C2B0 wds:Q30830558-25E615F9-E4B3-45F5-A192-A8A40ECF86A5 wds:Q30830558-387FC76F-AA0F-435C-AB60-79F6FBDB355D wds:Q30830558-EFD632EE-E953-4C38-A5E5-6C640F7B041E wds:Q30830558-43BED584-7C4D-4A04-88D3-EA526CDFE51C
wdt:P2860
wd:Q46620649 wd:Q35635718 wd:Q44731158 wd:Q44342598 wd:Q34233263 wd:Q37970666 wd:Q33924677 wd:Q48029140 wd:Q37991392 wd:Q43944191 wd:Q57830846 wd:Q37417660 wd:Q44671727 wd:Q34505653 wd:Q38003365 wd:Q34543617 wd:Q35853141 wd:Q44610613 wd:Q42553716 wd:Q37849790 wd:Q37959271 wd:Q43508711 wd:Q35609375 wd:Q42204402
p:P2093
wds:Q30830558-0CC71EAC-B37B-40E0-AF11-C2ADF6AD2B3C wds:Q30830558-3660FF0F-839E-4AF6-81BC-650078FE49B8 wds:Q30830558-97AC3DEF-542C-4906-A8CA-D0E867100D23 wds:Q30830558-FBFCD8A0-949B-4BD5-AD50-EEAE077127E6
wdt:P2093
Karl Weiss Cristina Calciu Patricia Hogan Kevin D Wolter
rdfs:label
Clinical cure rates in subjects treated with azithromycin for community-acquired respiratory tract infections caused by azithromycin-susceptible or azithromycin-resistant Streptococcus pneumoniae: analysis of Phase 3 clinical trial data Clinical cure rates in subjects treated with azithromycin for community-acquired respiratory tract infections caused by azithromycin-susceptible or azithromycin-resistant Streptococcus pneumoniae: analysis of Phase 3 clinical trial data Clinical cure rates in subjects treated with azithromycin for community-acquired respiratory tract infections caused by azithromycin-susceptible or azithromycin-resistant Streptococcus pneumoniae: analysis of Phase 3 clinical trial data
skos:prefLabel
Clinical cure rates in subjects treated with azithromycin for community-acquired respiratory tract infections caused by azithromycin-susceptible or azithromycin-resistant Streptococcus pneumoniae: analysis of Phase 3 clinical trial data Clinical cure rates in subjects treated with azithromycin for community-acquired respiratory tract infections caused by azithromycin-susceptible or azithromycin-resistant Streptococcus pneumoniae: analysis of Phase 3 clinical trial data Clinical cure rates in subjects treated with azithromycin for community-acquired respiratory tract infections caused by azithromycin-susceptible or azithromycin-resistant Streptococcus pneumoniae: analysis of Phase 3 clinical trial data
schema:name
Clinical cure rates in subjects treated with azithromycin for community-acquired respiratory tract infections caused by azithromycin-susceptible or azithromycin-resistant Streptococcus pneumoniae: analysis of Phase 3 clinical trial data Clinical cure rates in subjects treated with azithromycin for community-acquired respiratory tract infections caused by azithromycin-susceptible or azithromycin-resistant Streptococcus pneumoniae: analysis of Phase 3 clinical trial data Clinical cure rates in subjects treated with azithromycin for community-acquired respiratory tract infections caused by azithromycin-susceptible or azithromycin-resistant Streptococcus pneumoniae: analysis of Phase 3 clinical trial data
p:P50
wds:Q30830558-C3ECFDCB-9629-48AA-8FBC-01B6CD952389 wds:Q30830558-8C777F4B-94E2-4023-9A69-D50566D58CA5 wds:Q30830558-0703E855-F59A-4CA3-BED2-7B2CFB389091
wdt:P50
wd:Q60650638 wd:Q88392142 wd:Q87082624
p:P1476
wds:Q30830558-5EDF706D-67D4-4DCE-8B74-8359EE2DE647
wdt:P1476
Clinical cure rates in subjects treated with azithromycin for community-acquired respiratory tract infections caused by azithromycin-susceptible or azithromycin-resistant Streptococcus pneumoniae: analysis of Phase 3 clinical trial data
p:P304
wds:Q30830558-62B89332-48B7-42F9-BD78-777FE99CAB8F
wdt:P304
2835-2840
p:P31
wds:Q30830558-941F4F5E-61D9-4439-A163-13A529E700CE
wdt:P31
wd:Q13442814
p:P921
wds:Q30830558-2A5DF684-1CD0-460B-8CF9-5A584B23860A wds:Q30830558-461C3957-C1EC-4815-BFD3-74ABFC4F5D8E wds:Q30830558-C9364EFC-DB3F-45C6-B4EA-3C15A7ACD536
wdt:P921
wd:Q165399 wd:Q42824827 wd:Q221179
p:P698
wds:Q30830558-6AF62F0A-F4AC-4E02-9C71-4588ACE9E968
wdtn:P698
n11:24920652
wdt:P698
24920652
p:P1433
wds:Q30830558-20D3A39A-C0D6-483D-A840-C48EF5839B2F
wdt:P1433
wd:Q6294770
p:P433
wds:Q30830558-A27031FF-1CD3-4D88-9270-D46167C86609
p:P478
wds:Q30830558-3A90187F-D94C-46B2-BAA7-1A67175FBB7E
wdt:P433
10
wdt:P478
69
p:P1104
wds:Q30830558-B267B6D5-9414-4075-9E6C-66561C4515EA
wdt:P1104
6
p:P356
wds:Q30830558-491C41D5-FAE8-494B-AF5C-48E4DDC3B1DB
wdtn:P356
n12:DKU207
wdt:P356
10.1093/JAC/DKU207
p:P5875
wds:Q30830558-86B30B48-A3D5-4385-8727-A158EB52BDEA
wdt:P5875
263095661